logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

HR+ eBCa: adjuvant denosumab yields DFS benefit in ABCSG-18

Phase 3 data support benefits beyond fracture reduction in AI-treated postmenopausal women.